Xilio Therapeutics Inc (XLO)
0.7400 +0.0300 (+4.23%) 10:54 ET [NASDAQ]
0.7237 x 5 0.7394 x 5
Realtime by (Cboe BZX)
0.7237 x 5 0.7394 x 5
Realtime 0.7100 -0.0044 (-) 09:08 ET
for Tue, Apr 15th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,241 | -76,404 | -88,222 | -75,800 | -55,219 |
| Depreciation Amortization | 1,644 | 1,900 | 1,847 | 1,499 | 1,065 |
| Accounts payable and accrued liabilities | 1,526 | -2,063 | 485 | -2,818 | 2,926 |
| Other Working Capital | 33,302 | -2,346 | 1,660 | -8,667 | 14,320 |
| Other Operating Activity | 3,391 | 10,293 | 8,507 | 5,035 | 817 |
| Operating Cash Flow | $-18,378 | $-68,620 | $-75,723 | $-80,751 | $-36,091 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -486 | -1,867 | -1,100 | -2,188 |
| Investing Cash Flow | $-36 | $-486 | $-1,867 | $-1,100 | $-2,188 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 975 | N/A |
| Debt Repayment | -3,382 | -6,752 | -85 | -1,085 | -99 |
| Common Stock Issued | 32,578 | 202 | 16 | 116,642 | 159 |
| Other Financing Activity | 0 | 0 | 0 | 144,136 | 9,969 |
| Financing Cash Flow | $29,196 | $-6,550 | $-69 | $260,668 | $10,029 |
| Beginning Cash Position | 46,291 | 121,947 | 199,606 | 20,789 | 49,039 |
| End Cash Position | 57,073 | 46,291 | 121,947 | 199,606 | 20,789 |
| Net Cash Flow | $10,782 | $-75,656 | $-77,659 | $178,817 | $-28,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,378 | -68,620 | -75,723 | -80,751 | -36,091 |
| Capital Expenditure | -36 | -486 | -1,867 | -1,100 | -2,188 |
| Free Cash Flow | -18,414 | -69,106 | -77,590 | -81,851 | -38,279 |